Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (311-320 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Investigative Dermatology|June 29, 2019
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic DermatitisChris Callewaert, Teruaki Nakatsuji, Rob Knight, et al.
Journal of the American Academy of Dermatology|October 26, 2024
A phase 2a trial of brepocitinib for cicatricial alopeciaEden David, Neda Shokrian, Ester Del Duca, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2015
Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizerTali Czarnowicki, Dana Malajian, Saakshi Khattri, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2015
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarizationShinji Noda, Mayte Suárez-Fariñas, Benjamin Ungar, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2018
Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema CouncilKilian Eyerich, Sara J Brown, Bethany E Perez White, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2018
Early-onset pediatric atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>17/T<sub>H</sub>22-centered inflammation and lipid alterationsPatrick M Brunner, Ariel Israel, Ning Zhang, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosisAmy S Paller, Yael Renert-Yuval, Maria Suprun, et al.
Drug Discovery Today|February 22, 2025
Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunologyElena Peeva, Emma Guttman-Yassky, Yuji Yamaguchi, et al.
Clinical and Translational Science|July 30, 2024
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trialsMatthew P Kosloski, Emma Guttman-Yassky, Michael J Cork, et al.
Pageof 39

Showing results (311-320 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Investigative Dermatology|June 29, 2019
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic DermatitisChris Callewaert, Teruaki Nakatsuji, Rob Knight, et al.
Journal of the American Academy of Dermatology|October 26, 2024
A phase 2a trial of brepocitinib for cicatricial alopeciaEden David, Neda Shokrian, Ester Del Duca, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2015
Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizerTali Czarnowicki, Dana Malajian, Saakshi Khattri, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2015
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarizationShinji Noda, Mayte Suárez-Fariñas, Benjamin Ungar, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2018
Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema CouncilKilian Eyerich, Sara J Brown, Bethany E Perez White, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2018
Early-onset pediatric atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>17/T<sub>H</sub>22-centered inflammation and lipid alterationsPatrick M Brunner, Ariel Israel, Ning Zhang, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosisAmy S Paller, Yael Renert-Yuval, Maria Suprun, et al.
Drug Discovery Today|February 22, 2025
Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunologyElena Peeva, Emma Guttman-Yassky, Yuji Yamaguchi, et al.
Clinical and Translational Science|July 30, 2024
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trialsMatthew P Kosloski, Emma Guttman-Yassky, Michael J Cork, et al.
Pageof 39